Literature DB >> 17848915

Advances in behavioral genetics: mouse models of autism.

S S Moy1, J J Nadler.   

Abstract

Autism is a neurodevelopmental syndrome with markedly high heritability. The diagnostic indicators of autism are core behavioral symptoms, rather than definitive neuropathological markers. Etiology is thought to involve complex, multigenic interactions and possible environmental contributions. In this review, we focus on genetic pathways with multiple members represented in autism candidate gene lists. Many of these pathways can also be impinged upon by environmental risk factors associated with the disorder. The mouse model system provides a method to experimentally manipulate candidate genes for autism susceptibility, and to use environmental challenges to drive aberrant gene expression and cell pathology early in development. Mouse models for fragile X syndrome, Rett syndrome and other disorders associated with autistic-like behavior have elucidated neuropathology that might underlie the autism phenotype, including abnormalities in synaptic plasticity. Mouse models have also been used to investigate the effects of alterations in signaling pathways on neuronal migration, neurotransmission and brain anatomy, relevant to findings in autistic populations. Advances have included the evaluation of mouse models with behavioral assays designed to reflect disease symptoms, including impaired social interaction, communication deficits and repetitive behaviors, and the symptom onset during the neonatal period. Research focusing on the effect of gene-by-gene interactions or genetic susceptibility to detrimental environmental challenges may further understanding of the complex etiology for autism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17848915     DOI: 10.1038/sj.mp.4002082

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  87 in total

1.  Altered ultrasonic vocalizations in a tuberous sclerosis mouse model of autism.

Authors:  David M Young; A Katrin Schenk; Shi-Bing Yang; Yuh Nung Jan; Lily Yeh Jan
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

Review 2.  Fragile X syndrome: the GABAergic system and circuit dysfunction.

Authors:  Scott M Paluszkiewicz; Brandon S Martin; Molly M Huntsman
Journal:  Dev Neurosci       Date:  2011-09-21       Impact factor: 2.984

Review 3.  Oxytocin receptor and Mecp2 308/Y knockout mice exhibit altered expression of autism-related social behaviors.

Authors:  Roger L H Pobbe; Brandon L Pearson; D Caroline Blanchard; Robert J Blanchard
Journal:  Physiol Behav       Date:  2012-03-03

4.  A lifespan analysis of intraneocortical connections and gene expression in the mouse II.

Authors:  Catherine A Dye; Hani El Shawa; Kelly J Huffman
Journal:  Cereb Cortex       Date:  2010-11-08       Impact factor: 5.357

Review 5.  Cellular reprogramming: a novel tool for investigating autism spectrum disorders.

Authors:  Kun-Yong Kim; Yong Wook Jung; Gareth J Sullivan; Leeyup Chung; In-Hyun Park
Journal:  Trends Mol Med       Date:  2012-07-06       Impact factor: 11.951

Review 6.  Caenorhabditis elegans as an experimental tool for the study of complex neurological diseases: Parkinson's disease, Alzheimer's disease and autism spectrum disorder.

Authors:  Fernando Calahorro; Manuel Ruiz-Rubio
Journal:  Invert Neurosci       Date:  2011-11-08

Review 7.  Bench to cribside: the path for developing a neuroprotectant.

Authors:  Nelina Ramanantsoa; Bobbi Fleiss; Myriam Bouslama; Boris Matrot; Leslie Schwendimann; Charles Cohen-Salmon; Pierre Gressens; Jorge Gallego
Journal:  Transl Stroke Res       Date:  2012-12-21       Impact factor: 6.829

Review 8.  Stem cells and modeling of autism spectrum disorders.

Authors:  Beatriz C G Freitas; Cleber A Trujillo; Cassiano Carromeu; Marianna Yusupova; Roberto H Herai; Alysson R Muotri
Journal:  Exp Neurol       Date:  2012-10-02       Impact factor: 5.330

9.  Peripheral biomarkers in Autism: secreted amyloid precursor protein-alpha as a probable key player in early diagnosis.

Authors:  Antoinette R Bailey; Brian N Giunta; Demian Obregon; William V Nikolic; Jun Tian; Cyndy D Sanberg; Danielle T Sutton; Jun Tan
Journal:  Int J Clin Exp Med       Date:  2008-10-15

10.  NMDA receptor phosphorylation at a site affected in schizophrenia controls synaptic and behavioral plasticity.

Authors:  Bo Li; Nino Devidze; Denis Barengolts; Naseem Prostak; Eleana Sphicas; Alfonso J Apicella; Roberto Malinow; Effat S Emamian
Journal:  J Neurosci       Date:  2009-09-23       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.